Cited by 302Retinal Development and DisordersPhotoreceptor and optogenetics researchCircadian rhythm and melatonin

Restoration of visual function in retinal degeneration mice by ectopic expression of melanopsin

Open access
Lin, Bin, Koizumi, Amane, Tanaka, Nobushige, Panda, Satchidananda, Masland, Richard H.·2008·Proceedings of the National Academy of Sciences

Abstract

The rod and cone cells of the mammalian retina are the principal photoreceptors for image-forming vision. They transmit information by means of a chain of intermediate cells to the retinal ganglion cells, which in turn send signals from the retina to the brain. Loss of photoreceptor cells, as happens in a number of human diseases, leads to irreversible blindness. In a mouse model (rd/rd) of photoreceptor degeneration, we used a viral vector to express in a large number of retinal ganglion cells the light sensitive protein melanopsin, normally present in only a specialized subset of the cells. Whole-cell patch-clamp recording showed photoresponses in these cells even after degeneration of the photoreceptors and additional pharmacological or Cd(2+) block of synaptic function. Interestingly, similar responses were observed across a wide variety of diverse types of ganglion cell of the retina. The newly melanopsin-expressing ganglion cells provided an enhancement of visual function in rd/rd mice: the pupillary light reflex (PLR) returned almost to normal; the mice showed behavioral avoidance of light in an open-field test, and they could discriminate a light stimulus from a dark one in a two-choice visual discrimination alley. Recovery of the PLR was stable for at least 11 months. It has recently been shown that ectopic retinal expression of a light sensitive bacterial protein, channelrhodopsin-2, can restore neuronal responsiveness and simple visual abilities in rd/rd mice. For therapy in human photodegenerations, channelrhodopsin-2 and melanopsin have different advantages and disadvantages; both proteins (or modifications of them) should be candidates.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0806114105

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pre-clinical optogenetic trials in mouse models of retinitis pigmentosa have restored basic visual function in blind animals, providing proof of principle.

    “Pre-clinical trials of optogenic therapies in murine models of retinitis pigmentosa have provided proof-of-principle in restoring basic visual function to blind animals, and human clinical trials are currently underway.”

    From Correcting visual loss by genetics and prosthetics (2020) · cites this paper as Lin 2008

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 28 · Cited by 302

Authors
Lin, B., Koizumi, A., Tanaka, N., Panda, S., & Masland, R. H.
Affiliations
  • Harvard University (US)
  • Salk Institute for Biological Studies (US)
Venue
Proceedings of the National Academy of Sciences
Published
2008-10-14
Volume
105
Issue
41
Pages
16009-16014
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2088682369
Cited by
302
References
28
Citations by year
2026: 5 · 2025: 17 · 2024: 9 · 2023: 15 · 2022: 25 · 2021: 12 · 2020: 18 · 2019: 15 · 2018: 23 · 2017: 18 · 2016: 16 · 2015: 23 · 2014: 18 · 2013: 20 · 2012: 11
FWCI
7.81
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
Funders
National Eye Institute (R01EY016807, EY016807, R01EY017169, EY 017169)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Photoreceptor and optogenetics research
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
Keywords
melanopsin, retinal degeneration, retinal ganglion cells, ectopic expression, photoreceptor loss, pupillary light reflex, vision restoration, channelrhodopsin-2, viral vector gene therapy, photosensitivity
MeSH terms
Melanopsin, Animals, Light, Photic Stimulation, Retinal Degeneration, Retinal Ganglion Cells, Transduction, Genetic, Vision, Ocular, Rod Opsins, Photoreceptor Cells, Vertebrate, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review